Heart failure & cardiomyopathies

1. ESC Heart Fail12 May 2026

   Apical myocardial fibrosis burden identifies a high-risk phenotype and predicts cardiac mortality after LVAD implantation

   Cohort study

2. ESC Heart Fail11 May 2026

   Interaction of secondary ventricular tricuspid regurgitation with RV in HFREF: an invasive pressure-volume loop study

   Cohort study

3. J Am Coll Cardiol10 May 2026

   Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders: The EXCALIBUR Study

   Cohort study

4. Nat Med10 May 2026

   Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial

   Randomised controlled trial

5. Nat Med10 May 2026

   The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial

   Randomised controlled trial

6. JACC Heart Fail10 May 2026

   Survival Outcomes in Middle-Aged and Older Patients With Advanced Heart Failure: A Propensity-Matched Analysis of HeartMate 3 LVAD and Heart Transplant Using MOMENTUM 3 and UNOS Registry

   Cohort study

7. Eur J Heart Fail10 May 2026

   Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study

   Cross-sectional study

8. Circ Heart Fail10 May 2026

   Exploring Medication Adherence in Heart Failure From a Patient Perspective: A Qualitative Study

   Research article

9. Eur J Heart Fail10 May 2026

   Prevalence and predictors of high inflammatory risk in heart failure subtypes: findings from the global POSEIDON study

   Cohort study

10. Eur Heart J10 May 2026

    Renin–angiotensin–aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist devices: the MOMENTUM-3 trial

    Secondary analysis

11. Eur J Heart Fail10 May 2026

    Short- and long-term mortality in patients hospitalized for dyspnoea with acute heart failure, respiratory infection, or both: insights from the PARADISE cohort

    Cohort study

12. Eur J Heart Fail10 May 2026

    Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials

    Trial design

13. Circulation9 May 2026

    Angiotensin Receptor Neprilysin Inhibitor in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Regurgitation: The PRAISE-MR Randomized Trial

    Randomised controlled trial

14. Circ Heart Fail9 May 2026

    Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy

    Trial design

15. Eur J Heart Fail9 May 2026

    Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study

    Secondary analysis

16. ESC Heart Fail9 May 2026

    Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial

    Randomised controlled trial

17. Eur Heart J Cardiovasc Pharmacother7 May 2026

    Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study

    Cohort study

18. J Am Coll Cardiol6 May 2026

    Prospective Multicenter Evaluation of a Novel Active Driving System for Pediatric Ventricular Assist Device Support

    Cohort study

19. Circ Heart Fail6 May 2026

    Myosin ATPase Inhibition Relieves the Energetic Burden in Skeletal Myofibres of Patients With Heart Failure With Reduced Ejection Fraction

    Research article

20. Eur J Heart Fail5 May 2026

    Update on heart transplantation: a consensus document

    Guideline or statement

21. Europace5 May 2026

    Incidence and predictors of major arrhythmic events after myocarditis: a systematic review and meta-analysis

    Meta-analysis

22. ESC Heart Fail4 May 2026

    Congestion and renal function in patients with chronic heart failure

    Research article

23. Eur Heart J2 May 2026

    Cancer and heart failure: prevalence, incidence, and prognosis in Scotland

    Cohort study

24. JACC Heart Fail1 May 2026

    Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial

    Randomised controlled trial

25. JAMA Cardiol1 May 2026

    EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF

    Secondary analysis

26. JAMA Cardiol1 May 2026

    RBM20 Truncating Variants and Human Cardiomyopathy

    Cohort study

27. ESC Heart Fail30 Apr 2026

    Out-of-hours primary care management for patients with heart failure

    Research article

28. Eur Heart J Cardiovasc Pharmacother28 Apr 2026

    Initiation of eplerenone vs. spironolactone and all-cause mortality in HFrEF: linked database study

    Cohort study

29. ESC Heart Fail28 Apr 2026

    Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics: a clinical consensus statement of the Heart Failure Association of the ESC

    Guideline or statement

30. JACC Adv28 Apr 2026

    Long-Term Impact of Frailty on Outcomes Following Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

    Cohort study

31. Eur Heart J28 Apr 2026

    Sex differences in pharmacological treatment of heart failure: a meta-analysis of randomized trials

    Meta-analysis

32. JACC Heart Fail27 Apr 2026

    10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients

    Cohort study

33. Heart Rhythm27 Apr 2026

    External validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy–associated genetic variants

    Diagnostic or prognostic study

34. ESC Heart Fail27 Apr 2026

    Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure

    Cohort study

35. Eur J Heart Fail27 Apr 2026

    Kidney dysfunction and pulmonary vascular disease in heart failure with preserved ejection fraction

    Cohort study

36. Eur J Heart Fail27 Apr 2026

    Modification of the association between age and mortality in heart failure by frailty status

    Cohort study

37. Am Heart J25 Apr 2026

    Vasodilation, loop diuretics, or their combination in acute heart failure: Rationale and design of the randomized placebo-controlled DECONGEST-AHF trial

    Trial design

38. Circ Heart Fail24 Apr 2026

    Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure

    Randomised controlled trial

39. Eur Heart J Qual Care Clin Outcomes24 Apr 2026

    Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort study

    Cohort study

40. ESC Heart Fail24 Apr 2026

    The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis

    Meta-analysis

All 1,928 Briefs in ExploreShowing Briefs 441–480 of 1,928, newest first